Further Development and Validation of the frog Embryo Teratogenesis Assay - Xenopus (FETAX)
Abstract:
The goal of the project was to develop and validate the Frog Embryo Teratogenesis Assay- Xenopus FETAX. FETAX is a 96 h whole embryo bioassay designed to rapidly assess the developmental toxicity of pure compounds and complex mixtures. The five specific objectives of this study are 1 validate FETAX using direct-acting compounds of known mammalian developmental toxicity, 2 develop and validate an in vitro metabolic activation system using rat liver microsomes, 3 explore and use three carrier solvents which will help solubilize non-polar compounds, 4 develop an Atlas of Abnormalities as a companion manual to the ASTM New Standard Guide for the Conduct of FETAX and, 5 compare the sensitivity of FETAX with a fathead minnow bioassay modified to have the same exposure conditions as FETAX.